Drugs.com: More naloxone orders filled when pharmacists can dispense

UC research on naloxone dispensing makes headlines across the country

Pharmacy researchers at the University of Cincinnati unveiled an impactful research study on Jan. 31, 2020 that shows an association between a 2015 Ohio law and a surge in the dispensing of naloxone in Ohio pharmacies. Naloxone is the anti-overdose drug and pharmacists here can now legally dispense it in the state, without a prescription.

While the study focused solely on the increase in distribution of this lifesaving medication,  the implications are that death rates by overdose drop up to 14% in states where access is increased. As the opioid crisis continues to plague the U.S. and other countries, reporters from national, regional and local outlets took great interest in the study. The college dean, Neil MacKinnon, and lead faculty researcher, Pamela Heaton, participated in both televsion and print media interviews within days of the study's release.

A sample of the widespread interest includes: 

 

Featured image: generic pharmacy purchases/unsplash.com/Tbel Abuseridze

Related Stories

2

Study: Additional radiation for liver cancer does not increase toxicity

March 10, 2026

New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.

3

Is uACR the key to cardiovascular and kidney disease prevention?

March 8, 2026

As a precision biomarker, the urinary albumin-to-creatinine ratio (uACR) can guide physicians toward personalized, patient-centered prevention and treatment of both cardiovascular disease (CVD) and chronic kidney disease (CKD), according to new data published in the Journal of Internal Medicine.